Investors.abiomed.com

Investors Abiomed. Inc.'s business for stockholders, potential investors, and financial analysts.

What’s new on Investors.abiomed.com: Check updates and related news right now. Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Investors.abiomed.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Investors Abiomed

Subscribe to related news

Abiomed Inc. (ABMD) Shares Bought by Public Employees Retirement Association of Colorado
via baseballnewssource

Public Employees Retirement Association of Colorado increased its stake in Abiomed Inc. (NASDAQ:ABMD) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor...
ABIOMED, Inc. (NASDAQ: ABMD)
via todaysbigstock

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. It also manufactures and sells AB5000 circulatory...
Update: Abiomed Announced Clinical Trial Results For Impella RP
via seekingalpha

By Andy Batts: Abiomed (NASDAQ:ABMD) announced RECOVER RIGHT clinical trial results earlier this week. RECOVER RIGHT is an IDE (investigational device exemption) study for the company's Impella RP (right percutaneous) pump, the clinical results of which...
Sunshine Heart to Present at Upcoming Investor Conferences
via streetregister

EDEN PRAIRIE, Minn., Nov. 10, 2014 (Streetregister) — Sunshine Heart, Inc. (Nasdaq:SSH) announced today that the company is scheduled to present a corporate update at the following upcoming investor conferences for the balance of 2014: 2014 Credit Suisse...
Sunshine Heart Announces FDA Approval to Resume Enrollment in COUNTER HF(TM) US Pivotal Study for C-Pulse(R) Heart Assis...
via military-technologies

EDEN PRAIRIE, Minn., May 26, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) is pleased to announce that the US Food and Drug Administration (FDA) has approved the resumption of patient enrollment in its COUNTER HF US pivotal study for the...

Investors.abiomed.com popular pages

Investor Relations | ABIOMED, Inc.

The Investor Relations website contains information about ABIOMED, Inc.'s business for stockholders, potential investors, and financial analysts.
FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type

FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type Cardiopulmonary Bypass Blood Pumps Category DANVERS, Mass., Dec. 6, 2012 (G...

Abiomed Surpasses 20,000 Impella Patients in the United States | ABIOMED, Inc.

Abiomed Surpasses 20,000 Impella Patients in the United States DANVERS, Mass., June 3, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologi...